Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Banker

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Pacing and Clinical Electrophysiology : PACE|March 1, 1995
How do physicians determine when to perform an "on-drug" electrophysiology study for efficacy determination in patients with sustained ventricular tachyarrhythmias: a previously unaddressed variable that may affect efficacy ratesJ A Reiffel, J Banker
Current Drug Metabolism|November 11, 2008
Plasma/serum protein binding determinationsMichael J Banker, Tracey H Clark
The American Journal of Cardiology|March 15, 1997
Effects of the ventricular activation sequence on the JT intervalJ Banker, J Dizon, J Reiffel
Current Cardiology Reports|February 15, 2001
Pacemakers and defibrillators for congestive heart failureD Mehta, M N Langan, J Banker
Gene|April 15, 1988
A high-efficiency vector for expression of foreign genes in myeloma cellsM B Hendricks, M J Banker, M McLaughlin
Heart (British Cardiac Society)|April 16, 2009
Troponin T elevation after implanted defibrillator discharge predicts survivalD Blendea, M Blendea, J Banker, et al.
Journal of Pharmaceutical Sciences|April 25, 2003
Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein bindingMichael J Banker, Tracey H Clark, John A Williams
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|February 4, 2010
Problem formulation and option assessment (PFOA) linking governance and environmental risk assessment for technologies: a methodology for problem analysis of nanotechnologies and genetically engineered organismsKristen C Nelson, David A Andow, Michael J Banker
Journal of Inorganic Biochemistry|February 1, 2008
Isolation of a novel chromium(III) binding protein from bovine liver tissue after chromium(VI) exposureRyan L Peterson, Kelly J Banker, Thelma Y Garcia, et al.
Toxicology Letters|June 26, 2010
Predicting safety toleration of pharmaceutical chemical leads: cytotoxicity correlations to exploratory toxicity studiesJohn W Benbow, Jiri Aubrecht, Michael J Banker, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pacing and Clinical Electrophysiology : PACE|March 1, 1995
How do physicians determine when to perform an "on-drug" electrophysiology study for efficacy determination in patients with sustained ventricular tachyarrhythmias: a previously unaddressed variable that may affect efficacy ratesJ A Reiffel, J Banker
Current Drug Metabolism|November 11, 2008
Plasma/serum protein binding determinationsMichael J Banker, Tracey H Clark
The American Journal of Cardiology|March 15, 1997
Effects of the ventricular activation sequence on the JT intervalJ Banker, J Dizon, J Reiffel
Current Cardiology Reports|February 15, 2001
Pacemakers and defibrillators for congestive heart failureD Mehta, M N Langan, J Banker
Gene|April 15, 1988
A high-efficiency vector for expression of foreign genes in myeloma cellsM B Hendricks, M J Banker, M McLaughlin
Heart (British Cardiac Society)|April 16, 2009
Troponin T elevation after implanted defibrillator discharge predicts survivalD Blendea, M Blendea, J Banker, et al.
Journal of Pharmaceutical Sciences|April 25, 2003
Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein bindingMichael J Banker, Tracey H Clark, John A Williams
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|February 4, 2010
Problem formulation and option assessment (PFOA) linking governance and environmental risk assessment for technologies: a methodology for problem analysis of nanotechnologies and genetically engineered organismsKristen C Nelson, David A Andow, Michael J Banker
Journal of Inorganic Biochemistry|February 1, 2008
Isolation of a novel chromium(III) binding protein from bovine liver tissue after chromium(VI) exposureRyan L Peterson, Kelly J Banker, Thelma Y Garcia, et al.
Toxicology Letters|June 26, 2010
Predicting safety toleration of pharmaceutical chemical leads: cytotoxicity correlations to exploratory toxicity studiesJohn W Benbow, Jiri Aubrecht, Michael J Banker, et al.
Pageof 2